Related Experiment Videos
Prophylactic anticoagulation following acute myocardial infarction
Insights
Anticoagulation after myocardial infarction (MI) is not recommended for all patients. However, early heparin can prevent left ventricular thrombi (LVT) and strokes in high-risk MI patients, identified via echocardiogram.
Area of Science:
- Cardiology
- Neurology
- Thrombosis Research
Background:
- Anticoagulation is debated for myocardial infarction (MI) mortality benefit.
- Embolic cerebrovascular accidents (CVAs) are a concern post-MI.
- Routine anticoagulation post-MI is not justified due to risk-benefit ratio.
Purpose of the Study:
- Identify high-risk patients for left ventricular thrombi (LVT) and CVA post-MI.
- Evaluate the efficacy of early anticoagulation in preventing LVT and CVAs.
- Determine the role of echocardiography in risk stratification for anticoagulation.
Main Methods:
- Analysis of large trial data on anticoagulation post-MI.
- Identification of patient subgroups at high risk for LVT.
- Use of two-dimensional echocardiography for LVT detection before hospital discharge.
- Administration of heparin sodium for early anticoagulation.
- Consideration of warfarin sodium for post-hospitalization anticoagulation.
Main Results:
- Transmural anterior MI is associated with a 30-40% incidence of LVT.
- Early heparin sodium administration effectively prevents LVT formation.
- Early heparin sodium prevents CVAs in patients with high LVT risk.
- Echocardiography identifies patients needing anticoagulation post-discharge.
Conclusions:
- Not all myocardial infarction patients require anticoagulation.
- Targeted anticoagulation is beneficial for high-risk patients identified by echocardiography.
- Early anticoagulation with heparin sodium and subsequent warfarin can prevent LVT and CVAs.
Abstract:
Although several large trials have failed to demonstrate unequivocally that anticoagulation decreases mortality following myocardial infarction (MI), anticoagulation has been advocated to prevent embolic cerebrovascular accidents (CVAs). Since CVAs occur during hospitalization in only 1.5% to 3% of MIs, it is not justifiable to anticoagulate all patients after MI because the risk of anticoagulation exceeds the potential benefit. However, a group of patients who are at high risk of developing left ventricular thrombi (LVT) and CVA following MI can be identified. Thirty percent to 40% of patients with transmural anterior MI develop LVT, and early anticoagulation with heparin sodium prevents LVT formation and CVAs in this group. A two-dimensional echocardiogram before hospital discharge allows the identification of patients at risk for later embolization and helps determine the need for anticoagulation with warfarin sodium following hospitalization.